Edition:
India

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.44USD
18 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,865
52-wk High
$4.82
52-wk Low
$2.00

Chart for

About

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The Company focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It focuses on underserved therapeutic areas, such as central nervous system (CNS), including neurology and psychiatry, as well as... (more)

Overall

Beta: 1.69
Market Cap(Mil.): $34.83
Shares Outstanding(Mil.): 11.53
Dividend: --
Yield (%): --

Financials

  PTX.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -17.00 -- --
ROI: -74.47 15.07 14.61
ROE: -- 16.60 16.34

BRIEF-Pernix Therapeutics Announces Participation In Lead Bid Worldwide Rights Of Contrave

* PERNIX THERAPEUTICS ANNOUNCES PARTICIPATION IN LEAD BID FOR ACQUISITION OF WORLDWIDE RIGHTS TO CONTRAVE® FOR WEIGHT LOSS

23 Apr 2018

BRIEF-Pernix Therapeutics Reports Q4 Loss Per Share $2.78

* PERNIX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

09 Mar 2018

BRIEF-Pernix Announces Patent Litigation Settlement Agreement With Actavis

* PERNIX ANNOUNCES PATENT LITIGATION SETTLEMENT AGREEMENT WITH ACTAVIS CONCERNING ZOHYDRO® ER

29 Jan 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.80 --
Novartis AG (NOVN.S) CHF81.18 +0.52
Pfizer Inc. (PFE.N) $37.66 --
Roche Holding Ltd. (ROG.S) CHF232.80 -1.95
Roche Holding Ltd. (RO.S) CHF237.20 -1.60
Merck & Co., Inc. (MRK.N) $62.94 --

Earnings vs. Estimates